CStone Pharmaceuticals (HKG:2616)
Hong Kong
· Delayed Price · Currency is HKD 9.49
+0.07 (0.74%)
Apr 29, 2026, 4:08 PM HKT
CStone Pharmaceuticals Market Cap
CStone Pharmaceuticals has a market cap or net worth of 15.15 billion as of April 29, 2026. Its market cap has increased by 285.34% in one year.
Market Cap
15.15B
Enterprise Value
14.47B
Revenue
299.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
9.49
Market Cap Chart
Since February 26, 2019, CStone Pharmaceuticals's market cap has increased from 12.65B to 15.15B, an increase of 19.73%. That is a compound annual growth rate of 2.54%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanjing Leads Biolabs | 16.48B |
| Ascentage Pharma Group International | 17.22B |
| CARsgen Therapeutics Holdings | 13.30B |
| Everest Medicines | 13.00B |
| Zai Lab | 20.04B |
| Ascletis Pharma | 20.32B |
| HBM Holdings | 11.70B |
| Alphamab Oncology | 10.87B |